Indivior PLC (INDV)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Indivior PLC (INDV)
Company Performance

Current Price

as of Oct 16, 2024

$8.09

P/E Ratio

N/A

Market Cap

$1.05B

Description

Indivior PLC is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in North Chesterfield, VA.

Metrics

Overview

  • HQNorth Chesterfield, VA
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • TickerINDV
  • Price$8.094739+5.80%

Trading Information

  • Market Cap$1.05B
  • Float99.53%
  • Average Daily Volume (1m)663,367
  • Average Daily Volume (3m)541,620
  • EPS-$0.81

Company

  • Revenue$911.29M
  • Rev Growth (1yr)7.48%
  • Net Income-$84.80M
  • Gross Margin61.20%
  • EBITDA Margin20.07%
  • EBITDA$47.55M
  • EV$1.59B
  • EV/Revenue1.75
  • P/EN/A
  • P/S0.92
  • P/BN/A
Documents